Two Sigma Securities’s Kiora Pharmaceuticals KPRX Stock Holding History

Two Sigma Securities’s Portfolio KPRX Stock Details KPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12,019	Closed	-$23.2K	–	2086
2026 Q1	$23.2K	Buy	+12,019	New	+$25.4K	﹤0.01%	1356
2023 Q3	–	Sell	-1,370	Closed	-$7.93K	–	3230
2023 Q2	$7.93K	Buy	+1,370	New	+$28.7K	﹤0.01%	2623
2019 Q3	–	Sell	-8	Closed	-$10K	–	2267
2019 Q2	$10K	Buy	+8	New	+$11.8K	﹤0.01%	1991
2018 Q4	–	Sell	-10	Closed	-$17K	–	2520
2018 Q3	$17K	Buy	+10	New	+$26.9K	﹤0.01%	2460
2018 Q2	–	Sell	-2	Closed	-$5K	–	2843
2018 Q1	$5K	Sell	2 -4	-67%	-$17.3K	﹤0.01%	2624
2017 Q4	$33K	Hold	6	–	–	﹤0.01%	1584
2017 Q3	$37K	Buy	+6	New	+$38.2K	﹤0.01%	771
2017 Q2	–	Sell	-2	Closed	-$26K	–	1031
2017 Q1	$26K	Buy	+2	New	+$22.4K	0.01%	837

Other funds holding KPRX

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SRL

Scientech Research LLC Jersey City, New Jersey $123M AUM 198.31% 1-Year Est. Return

Two Sigma Securities's KPRX Position: Q2 2026 in Review

Two Sigma Securities sold out of Kiora Pharmaceuticals (KPRX) in Q2 2026, closing a stake of 12,019 shares — an estimated $23.2K sold.

Two Sigma Securities first reported a position in KPRX in Q1 2017 and held it in 8 quarters. The position peaked at $37K in Q3 2017. 22 funds tracked by Wall St. Rank hold KPRX as of Q2 2026.

Two Sigma Securities reported no remaining Kiora Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Two Sigma Securities sold 12,019 Kiora Pharmaceuticals shares in Q2 2026, an estimated $23.2K.
Two Sigma Securities first reported a position in Kiora Pharmaceuticals in Q1 2017 and held it in 8 quarters.
Two Sigma Securities's Kiora Pharmaceuticals position peaked at $37K in Q3 2017.
22 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.